other material
confidence high
sentiment neutral
materiality 0.35
Petros Pharmaceuticals amends Series A Preferred to grant voting rights at $2.25 conversion price
Petros Pharmaceuticals, Inc.
- Amendment grants Series A Preferred holders voting rights on as-converted basis at $2.25/share conversion price.
- Certificate of Amendment filed with Delaware Secretary of State, effective October 11, 2024.
- Required Holders (majority of outstanding preferred) agreed; no additional consideration paid to investors.
- Amendment modifies terms from original July 2023 Securities Purchase Agreement; no other changes to transaction documents.